Skip to Content

MD Anderson’s Thoracic Center provides personalized care for every type and stage of lung cancer and other cancers in the chest region. Our nationally recognized expertise allows us to offer hope for lung cancer patients whose disease may be considered untreatable elsewhere.

Lung cancer and mesothelioma often require a combination of treatments. Our surgeons, medical oncologists and radiation oncologists will create a multidisciplinary treatment plan based on your exact diagnosis.

Proton therapy, highly focused radiation treatments and minimally invasive, video-assisted thoracoscopic surgery (VATS) are just some of the treatment options that can be used alone or in combination to treat your cancer.

Clinical research doctors in the Thoracic Center are developing new mesothelioma treatments, many of which are only available in MD Anderson clinical trials. A team of more than 30 mesothelioma experts work together to customize treatment and provide ongoing patient support.

It’s our mission to ensure that our patients have the best possible life after cancer, with advanced treatment techniques to preserve lung function. 

Types of cancers we treat:

  • Lung cancer
  • Esophageal cancer 
  • Mesothelioma
  • Thymoma 
  • Cancers of the trachea, chest wall, pericardium and pulmonary system

Cancer is serious. And I am seriously determined to get well.

Mary Ginley


Need Directions?

The Thoracic Center is located in the Main Building, Floor 9, near Elevator B.

Knowledge Center

Find the latest news and information in our Knowledge Center, including blog posts, articles, videos, news releases and more.

Clinical Trials

MD Anderson patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.

MD Anderson Resources

Prevention & Screening

Many cancers can be prevented with lifestyle changes and regular screening.

Contact Us

The Thoracic Center business hours are 8 a.m. to 5 p.m., Monday through Friday. 


  • 713-792-6110 (Current patients)
  • 877-632-6789 (New patients)
  • 713-745-5353 (Clinical trial information)